Arkolith/Insider Trading/TNGX/Form 4

Crystal Adam

President, R&DTango Therapeutics, Inc. (TNGX) · full profile →Form 4 · filed Feb 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$694K
Net Open-Market Flow
-$694K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 25, 2026Sell(S)54K$12.77$694K133K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-083579) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML